DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

Biogen Idec (NASDAQ: BIIB)

396.99 -3.11 (-0.78%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

BIIB $396.99 -0.78%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $400.09
Previous Close $400.10
Daily Range $395.64 - $401.89
52-Week Range $290.85 - $480.18
Market Cap $93.4B
P/E Ratio 28.91
Dividend (Yield) $0.00 (0.0%)
Volume 1,302,038
Average Daily Volume 1,821,308
Current FY EPS $16.70

Sector

Healthcare

Industry

Drug Makers

Biogen Idec (BIIB) Description

The Company creates new standards of care in oncology, neurology, immunology and other specialty areas of unmet medical need and engaged in the development, manufacturing, and commercialization of novel therapies. Website: http://www.biogenidec.com/

News & Commentary

Pop! 3 To Buy If Biotech Stocks Burst

Biotech stocks are falling slightly from their lofty levels, and that may create some interesting opportunities to buy.

Apple, SunEdison and Biogen: Hellman, Jordan Management's Top 3 Stocks Outperform the Rise in ...

OEF, ABBV, BA, BIIB: ETF Outflow Alert

Short Sellers Get Even More Ambitious Against Biotech Leaders

Jim Cramer -- Stocks Went From Hungover to Drunk in 24 Hours

PRIMECAP Sells Portions of Its Top Two Stakes

Amazon, Apple and Chipotle Too Pricey for Your Portfolio? There's an ETF for That

Healthcare Investment Opportunities for the Long Term

Three healthcare investment opportunities that could be profitable for decades to come.

Stock Market News for May 21, 2015 - Market News

Jim Cramer Answers Your Twitter Questions on Tesla, Jarden, Williams-Sonoma, Wayfair

See More BIIB News...

BIIB's Top Competitors

BIIB $396.99 (-0.78%)
Current stock: BIIB
$0.00 (0.00%)
Current stock:
AMGN $156.26 (-0.69%)
Current stock: AMGN
CELG $114.44 (-0.43%)
Current stock: CELG